相似文献
1
Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.
Antimicrob Agents Chemother. 1975 Aug;8(2):224-5. doi: 10.1128/AAC.8.2.224.
2
Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
Rev Infect Dis. 1979 Jan-Feb;1(1):106-12. doi: 10.1093/clinids/1.1.106.
3
Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
Scand J Infect Dis Suppl. 1980;suppl 25:60-5.
4
[In vitro susceptibility of bacteroidaceae to cefoxitin and cephalothin (author's transl)].
Infection. 1977;5(1):13-6. doi: 10.1007/BF01639103.
5
beta-lactamases in bacteroides.
Scand J Infect Dis Suppl. 1978(13):27-32.
6
In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.
Antimicrob Agents Chemother. 1975 May;7(5):698-703. doi: 10.1128/AAC.7.5.698.
7
Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.
Diagn Microbiol Infect Dis. 1987 Jun;7(2):119-26. doi: 10.1016/0732-8893(87)90029-0.
8
Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
Infection. 1991 Mar-Apr;19(2):101-5. doi: 10.1007/BF01645577.
9
The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections.
J Antimicrob Chemother. 1978 Jul;4(B):239-40. doi: 10.1093/jac/4.suppl_b.239.
10
Studies with cefuroxime and cefoxitin.
Scand J Infect Dis Suppl. 1978(13):78-81.
引用本文的文献
1
Comparison of extracellular enzymes of Fusobacterium necrophorum subsp. necrophorum and Fusobacterium necrophorum subsp. funduliforme.
J Clin Microbiol. 1993 Aug;31(8):2244-7. doi: 10.1128/jcm.31.8.2244-2247.1993.
2
Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).
Infection. 1980;8 Suppl 2:S182-6. doi: 10.1007/BF01639888.
3
Susceptibility of anaerobic bacteria to cofoxitin and related compounds.
Antimicrob Agents Chemother. 1977 May;11(5):912-3. doi: 10.1128/AAC.11.5.912.
4
[In vitro susceptibility of bacteroidaceae to cefoxitin and cephalothin (author's transl)].
Infection. 1977;5(1):13-6. doi: 10.1007/BF01639103.
5
Chemotherapy of an experimental Bacteroides fragilis infection in mice.
Antimicrob Agents Chemother. 1977 Mar;11(3):435-40. doi: 10.1128/AAC.11.3.435.
6
Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.
Antimicrob Agents Chemother. 1978 Nov;14(5):755-60. doi: 10.1128/AAC.14.5.755.
7
Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
Drugs. 1979 Jan;17(1):1-37. doi: 10.2165/00003495-197917010-00001.
8
Fusobacterium necrophorum: its characteristics and role as an animal pathogen.
Bacteriol Rev. 1977 Jun;41(2):373-90. doi: 10.1128/br.41.2.373-390.1977.
本文引用的文献
1
Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice.
Antimicrob Agents Chemother. 1974 Jun;5(6):658-62. doi: 10.1128/AAC.5.6.658.
2
Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.
Antimicrob Agents Chemother. 1974 Jan;5(1):25-32. doi: 10.1128/AAC.5.1.25.
3
In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.
Antimicrob Agents Chemother. 1975 May;7(5):698-703. doi: 10.1128/AAC.7.5.698.
Zotero 插件